Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther. 2019;21(2):66–72.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Yeh H-C, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med. 2012;157(5):336–47.

PubMed  Article  Google Scholar 

American Diabetes Association Professional Practice Committee. 7. Diabetes technology: standards of medical care in diabetes—2022. Diabetes Care. 2022;45(Supplement_1):S97–S112.

Maiorino MI, Signoriello S, Maio A, Chiodini P, Bellastella G, Scappaticcio L, et al. Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146–56.

CAS  PubMed  Article  Google Scholar 

Galindo RJ, Parkin CG, Aleppo G, Carlson AL, Kruger DF, Levy CJ, et al. What’s wrong with this picture? A critical review of current centers for medicare & medicaid services coverage criteria for continuous glucose monitoring. Diabetes Technol Ther. 2021;23(9):652–60.

PubMed  PubMed Central  Article  Google Scholar 

Thabit H, Prabhu JN, Mubita W, Fullwood C, Azmi S, Urwin A, et al. Use of factory-calibrated real-time continuous glucose monitoring improves time in target and HbA1c in a multiethnic cohort of adolescents and young adults with type 1 diabetes: the MILLENNIALS study. Diabetes Care. 2020;43(10):2537–43.

CAS  PubMed  Article  Google Scholar 

Teoh IH, Prabhu J, Mubita W, Azmi S, Urwin A, Doughty I, et al. Real-time continuous glucose monitoring benefits glycemic control in adolescents and young adults with type 1 diabetes irrespective of insulin delivery modality: subanalysis of the MILLENNIAL Study. J Diabetes Sci Technol. 2021;16(1):252–3.

PubMed  Article  Google Scholar 

Tumminia A, Crimi S, Sciacca L, Buscema M, Frittitta L, Squatrito S, et al. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial. Diabetes Metab Res Rev. 2015;31(1):61–8.

CAS  PubMed  Article  Google Scholar 

Hohendorff J, Gumprecht J, Mysliwiec M, Zozulinska-Ziolkiewicz D, Malecki MT. Intermittently scanned continuous glucose monitoring data of Polish patients from real-life conditions: more scanning and better glycemic control compared to worldwide data. Diabetes Technol Ther. 2021;23(8):577–85.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Reddy M, Jugnee N, El Laboudi A, Spanudakis E, Anantharaja S, Oliver N. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with type 1 diabetes and impaired awareness of hypoglycaemia. Diabet Med. 2018;35(4):483–90.

CAS  PubMed  Article  Google Scholar 

Hásková A, Radovnická L, Petruželková L, Parkin CG, Grunberger G, Horová E, et al. Real-time CGM is superior to flash glucose monitoring for glucose control in type 1 diabetes: the CORRIDA randomized controlled trial. Diabetes Care. 2020;43(11):2744–50.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Polonsky WH, Fortmann AL. Impact of real-time CGM data sharing on quality of life in the caregivers of adults and children with type 1 diabetes. J Diabetes Sci Technol. 2020;16(1):97–105.

PubMed  PubMed Central  Article  Google Scholar 

Tanenbaum ML, Zaharieva DP, Addala A, Ngo J, Prahalad P, Leverenz B, et al. ‘I was ready for it at the beginning’: parent experiences with early introduction of continuous glucose monitoring following their child’s type 1 diabetes diagnosis. Diabet Med. 2021;38(8):e14567.

PubMed  PubMed Central  Article  Google Scholar 

Gilbert TR, Noar A, Blalock O, Polonsky WH. Change in hemoglobin A1c and quality of life with real-time continuous glucose monitoring use by people with insulin-treated diabetes in the landmark study. Diabetes Technol Ther 2021;23(S1):S-35-S-9.

Polonsky WH, Fortmann AL. Impact of real-time continuous glucose monitoring data sharing on quality of life and health outcomes in adults with type 1 diabetes. Diabetes Technol Ther. 2021;23(3):195–202.

PubMed  PubMed Central  Article  Google Scholar 

Da Silva J, Lepore G, Battelino T, Arrieta A, Castañeda J, Grosman B, et al. Real-world performance of the MiniMed™ 780G system: first report of outcomes from 4,120 users. Diabetes Technol Ther 2021(ja).

Bergenstal RM, Nimri R, Beck RW, Criego A, Laffel L, Schatz D, et al. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. Lancet. 2021;397(10270):208–19.

CAS  PubMed  Article  Google Scholar 

Forlenza GP, Ekhlaspour L, Breton M, Maahs DM, Wadwa RP, DeBoer M, et al. Successful at-home use of the tandem Control-IQ artificial pancreas system in young children during a randomized controlled trial. Diabetes Technol Ther. 2019;21(4):159–69.

PubMed  PubMed Central  Article  Google Scholar 

Breton MD, Kovatchev BP. One year real-world use of the Control-IQ advanced hybrid closed-loop technology. Diabetes Technol Ther. 2021;23(9):601–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Sherr JL, Buckingham BA, Forlenza GP, Galderisi A, Ekhlaspour L, Wadwa RP, et al. Safety and performance of the omnipod hybrid closed-loop system in adults, adolescents, and children with type 1 diabetes over 5 days under free-living conditions. Diabetes Technol Ther. 2020;22(3):174–84.

PubMed  PubMed Central  Article  Google Scholar 

Buckingham BA, Forlenza GP, Criego AB, Hansen DW, Bode BW, Brown SA, et al. Safety evaluation of the Omnipod® 5 automated insulin delivery system over three months of use in children with type 1 diabetes (T1D). J Endocr Soc. 2021;5(Supplement_1):A454–A.

PubMed Central  Article  Google Scholar 

Musolino G, Dovc K, Boughton CK, Tauschmann M, Allen JM, Nagl K, et al. Reduced burden of diabetes and improved quality of life: experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes. Pediatr Diabetes. 2019;20(6):794–9.

PubMed  PubMed Central  Google Scholar 

Abraham MB, de Bock M, Smith GJ, Dart J, Fairchild JM, King BR, et al. Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with type 1 diabetes: a randomized clinical trial. JAMA Pediatr. 2021.

Cobry EC, Kanapka LG, Cengiz E, Carria L, Ekhlaspour L, Buckingham BA, et al. Health-related quality of life and treatment satisfaction in parents and children with type 1 diabetes using closed-loop control. Diabetes Technol Ther. 2021;23(6):401–9.

PubMed  Article  Google Scholar 

Cobry EC, Hamburger E, Jaser SS. Impact of the hybrid closed-loop system on sleep and quality of life in youth with type 1 diabetes and their parents. Diabetes Technol Ther. 2020;22(11):794–800.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tanenbaum ML, Hanes SJ, Miller KM, Naranjo D, Bensen R, Hood KK. Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care. 2017;40(2):181–7.

PubMed  Article  Google Scholar 

Messer LH, Tanenbaum ML, Cook PF, Wong JJ, Hanes SJ, Driscoll KA, et al. Cost, hassle, and on-body experience: Barriers to diabetes device use in adolescents and potential intervention targets. Diabetes Technol Ther. 2020;22(10):760–7.

PubMed  Article  Google Scholar 

Aleppo G, Parkin CG, Carlson A, Galindo R, Kruger D, Levy C, et al. Lost in Translation. A disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion (CSII). Diabetes Technol Ther. 2021;(ja).

Chen CW, Tinsley LJ, Volkening LK, Anderson BJ, Laffel LM. Observed characteristics associated with diabetes device use among teens with type 1 diabetes. Journal of diabetes science and technology. 2021;Online ahead of print.

DeSalvo DJ, Noor N, Xie C, Corathers SD, Majidi S, McDonough RJ, et al. Patient demographics and clinical outcomes among type 1 diabetes patients using continuous glucose monitors: data from T1D exchange real-world observational study. Journal of diabetes science and technology. 2021;Online ahead of print.

Everett EM, Wisk LE. Relationships between socioeconomic status, insurance coverage for diabetes technology and adverse health in patients with type 1 diabetes. Journal of diabetes science and technology. 2021;Online ahead of print.

Walker AF, Hood KK, Gurka MJ, Filipp SL, Anez-Zabala C, Cuttriss N, et al. Barriers to technology use and endocrinology care for underserved communities with type 1 diabetes. Diabetes Care. 2021.

Lal RA, Basina M, Maahs DM, Hood K, Buckingham B, Wilson DM. One year clinical experience of the first commercial hybrid closed-loop system. Diabetes Care. 2019;42(12):2190–6.

PubMed  PubMed Central  Article  Google Scholar 

Agarwal S, Schechter C, Gonzalez J, Long JA. Racial–ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther. 2021;23(4):306–13.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ju Z, Piarulli A, Bielick L, Marschall S, Broiullard E, Steenkamp D. Advanced diabetes technology remains underutilized in underserved populations: early hybrid closed loop system experience at an academic safety net hospital. Diabetes Technol Ther 2021(ja).

Agarwal S, Crespo-Ramos G, Long JA, Miller VA. “I didn’t really have a choice”: qualitative analysis of racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther 2021(ja).

Lawton J, Kimbell B, Rankin D, Ashcroft NL, Varghese L, Allen JM, et al. Health professionals’ views about who would benefit from using a closed-loop system: a qualitative study. Diabet Med. 2020;37(6):1030–7.

CAS  PubMed  Article  Google Scholar 

Farrington C, Hovorka R, Murphy HR. Who should access closed-loop technology? A qualitative study of clinician attitudes in England. Diabetes Technol Ther. 2020;22(5):404–10.

PubMed  PubMed Central  Article  Google Scholar 

Lawton J, Kirkham J, Rankin D, White DA, Elliott J, Jaap A, et al. Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE) trial. Diabet Med. 2016;33(2):243–51.

CAS  PubMed  Article  Google Scholar 

Farrington C, Murphy H, Hovorka R. A qualitative study of clinician attitudes towards closed-loop systems in mainstream diabetes care in England. Diabet Med. 2020;37(6):1023–9.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tanenbaum ML, Adams RN, Hanes SJ, Barley RC, Miller KM, Mulvaney SA, et al. Optimal use of diabetes devices: clinician perspectives on barriers and adherence to device use. J Diabetes Sci Technol. 2017;11(3):484–92.

PubMed  PubMed Central  Article  Google Scholar 

Lanning MS, Tanenbaum ML, Wong JJ, Hood KK. Barriers to continuous glucose monitoring in people with type 1 diabetes: clinician perspectives. Diabetes Spectrum. 2020;33(4):324–30.

PubMed  PubMed Central  Article  Google Scholar 

Bergloff A, Stratton E, Briggs EK. A cross-sectional pilot survey of rural clinic attitudes and proficiency with insulin pumps and continuous glucose monitoring devices. Diabetes Technol Ther. 2019;21(11):665–70.

PubMed  Article  Google Scholar 

Forlenza GP, Argento NB, Laffel LM. Practical considerations on the use of continuous glucose monitoring in pediatrics and older adults and nonadjunctive use. Diabetes Technol Ther. 2017;19(S3):S-13–20.

Article  Google Scholar 

Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR, et al. Benefits and barriers of continuous glucose monitoring in young children with type 1 diabetes. Diabetes Technol Ther. 2019;21(9):493–8.

PubMed  PubMed Central  Article  Google Scholar 

Commissariat PV, Whitehouse AL, Hilliard ME, Miller KM, Harrington KR, Levy W, et al. Sources and valence of information impacting parents’ decisions to use diabetes technologies in young children< 8 years old with type 1 diabetes. Diabetes Technol Ther. 2020;22(9):697–700.